Business / Finance

RSS

BGI extends cash tender offer to purchase all outstanding shares of Complete Genomics

BGI-Shenzhen announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. to 12:00 midnight on Wednesday, February 6, 2013.

2 Feb 2013

Pharmacuetical companies eye orphan drugs as new revenue source

Drug companies are fond of saying that every patient counts, but in the world of orphan diseases, entire business plans are built around the idea. ... Development of these drugs is increasingly attractive to pharmaceutical companies, which are searching for new sources of revenue as sales of more traditional, mass-market drugs have been lost to generic competition.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

Acadia acquires Delta Medical Center

Acadia Healthcare Company, Inc. today announced the purchase of Delta Medical Center, a 243-bed hospital in Memphis, TN, with the majority of operating beds dedicated to acute inpatient psychiatric patients.

1 Feb 2013

Selway signs definitive agreement to enter into business combination with HCCA

Selway Capital Acquisition Corporation announced today that it has signed a definitive agreement to enter into a business combination with Healthcare Corporation of America, Inc. (HCCA), which is one of the fastest growing PBM's in the market.

31 Jan 2013

Major East Coast academic medical center acquires BSD-500 Hyperthermia System

BSD Medical Corporation announced today that a major East Coast academic medical center has purchased a BSD-500 Hyperthermia System (BSD-500).

31 Jan 2013

Span-America first quarter net income increases 21% to $1.4 million

Span-America Medical Systems, Inc. today reported higher sales and net income for the first quarter ended December 29, 2012.

31 Jan 2013

Affymetrix fourth quarter total revenue increases 2% to $84.4 million

Affymetrix, Inc., today reported its operating results for the three and twelve months ended December 31, 2012.

31 Jan 2013

DelMar announces second closing of $1.5M in private placement

DelMar Pharmaceuticals, Inc. today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 million. The total amount raised in the private placement is $6.9 million.

31 Jan 2013

Linden acquires Young Innovations

Young Innovations, Inc. today announced the completion of its acquisition by affiliates of Linden Capital Partners in an all-cash transaction valued at approximately $314 million.

31 Jan 2013

McKesson third quarter revenues increase 1% to $31.2 billion

McKesson Corporation today reported that revenues for the third quarter ended December 31, 2012 were $31.2 billion, up 1% compared to $30.8 billion a year ago. On the basis of U.S. generally accepted accounting principles, third-quarter earnings per diluted share was $1.24 compared to $1.20 a year ago.

31 Jan 2013

Oclaro second quarter revenues increase to $159.5 million

Oclaro, Inc., a provider of optical components, modules and subsystems, today announced the financial results for its second quarter of fiscal year 2013, which ended December 29, 2012.

31 Jan 2013

Abaxis third quarter revenues increase 32% to $49.8 million

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the third fiscal quarter ended December 31, 2012.

31 Jan 2013

Zimmer fourth quarter net sales increase to $1.18 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2012. The Company reported fourth quarter net sales of $1.18 billion, an increase of 1.1% reported and 2.1% constant currency over the fourth quarter of 2011.

31 Jan 2013

Teva terminates collaboration with CureTech

Teva Pharmaceutical Industries Ltd. announced today the termination of its collaboration with CureTech Ltd.

31 Jan 2013

Texas College of Traditional Chinese Medicine announces change of name

Texas College of Traditional Chinese Medicine announces the change of its name to Texas Health and Science University. "Our name change means another giant step to move the school's global efforts to work with more universities and implement our strategic initiatives!" says Lisa Ping Hui Lin, E.M.B.A., President and Chief Executive Officer.

31 Jan 2013

Keryx prices underwritten public offering of common stock

Keryx Biopharmaceuticals, Inc. today announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share.

30 Jan 2013

Foresee, ScinoPharm to form joint venture for new oncological Leuprolide injectable drug

ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and transferred to the joint venture.

30 Jan 2013

Glenmark third quarter consolidated revenue increases 33.96% to Rs. 13812.59M

Glenmark Pharmaceuticals Limited (GPL), the research-led global integrated pharmaceutical company announced its results for the third quarter ended December 31, 2012.

30 Jan 2013